Welcome to our dedicated page for Sartorius news (Ticker: SOAGY), a resource for investors and traders seeking the latest updates and insights on Sartorius stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Sartorius's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Sartorius's position in the market.
Sartorius AG's Annual General Shareholders' Meeting on March 25, 2022, resulted in significant decisions. Shareholders approved discharges for the Executive and Supervisory Boards and endorsed the proposal to distribute dividends of 1.26 euros per preference share and 1.25 euros per ordinary share, amounting to 85.9 million euros, a notable increase from the previous year's dividends of 0.71 euros and 0.70 euros respectively. Additionally, new supervisory board members were elected, including digital expert Frank Riemensperger.
FAQ
What is the current stock price of Sartorius (SOAGY)?
What is the market cap of Sartorius (SOAGY)?
